Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2010, Article ID 414676, 11 pages
http://dx.doi.org/10.1155/2010/414676
Review Article

Targeting the EGF Receptor for Ovarian Cancer Therapy

1Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM 87131-0001, USA
2Department of Obstetrics and Gynecology, School of Medicine, University of New Mexico, Albuquerque, NM 87131-0001, USA
3Department of Pathology and Anatomical Sciences, University of Missouri School of Medicine, Columbia, MO 65212, USA

Received 15 June 2009; Accepted 11 September 2009

Academic Editor: Maurie M. Markman

Copyright © 2010 Reema Zeineldin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [33 citations]

The following is the list of published articles that have cited the current article.

  • Lucia M. A. Crane, Marleen van Oosten, Rick G. Pleijhuis, Arash Motekallemi, Sean C. Dowdy, William A. Cliby, Ate G. J. van der Zee, and Gooitzen M. van Dam, “Intraoperative Imaging in Ovarian Cancer: Fact or Fiction?,” Molecular Imaging, vol. 10, no. 4, pp. 248–257, 2011. View at Publisher · View at Google Scholar
  • Elena Appel, Aharon Rabinkov, Michal Neeman, Fortune Kohen, and David Mirelman, “Conjugates of daidzein-alliinase as a targeted pro-drug enzyme system against ovarian carcinoma,” Journal Of Drug Targeting, vol. 19, no. 5, pp. 326–335, 2011. View at Publisher · View at Google Scholar
  • Paul S. Kim, Shabdis Djazayeri, and Reema Zeineldin, “Novel nanotechnology approaches to diagnosis and therapy of ovarian cancer,” Gynecologic Oncology, vol. 120, no. 3, pp. 393–403, 2011. View at Publisher · View at Google Scholar
  • Hiroshi Tsujioka, Fusanori Yotsumoto, Shoko Hikita, Taeko Ueda, Masahide Kuroki, and Shingo Miyamoto, “Targeting the heparin-binding epidermal growth factor-like growth factor in ovarian cancer therapy,” Current Opinion In Obstetrics & Gynecology, vol. 23, no. 1, pp. 24–30, 2011. View at Publisher · View at Google Scholar
  • Imran Rizvi, Tri A. Dinh, Weiping Yu, Yuchiao Chang, Margaret E. Sherwood, and Tayyaba Hasan, “Photoimmunotherapy and Irradiance Modulation Reduce Chemotherapy Cycles and Toxicity in a Murine Model for Ovarian Carcinomatosis: Perspective and Results,” Israel Journal of Chemistry, vol. 52, no. 8-9, pp. 776–787, 2012. View at Publisher · View at Google Scholar
  • Sivakumar Loganathan, Prabodh K. Kandala, Parul Gupta, and Sanjay K. Srivastava, “Inhibition of EGFR-AKT axis results in the suppression of ovarian tumors in vitro and in preclinical mouse model,” PLoS ONE, vol. 7, no. 8, 2012. View at Publisher · View at Google Scholar
  • Eshrat Gharaei Fathabadi, Andrew N. Shelling, and Raida Al-Kassas, “Nanocarrier systems for delivery of siRNA to ovarian cancer tissues,” Expert Opinion on Drug Delivery, vol. 9, no. 7, pp. 743–754, 2012. View at Publisher · View at Google Scholar
  • Prabodh K. Kandala, Stephen E. Wright, and Sanjay K. Srivastava, “Blocking Epidermal Growth Factor Receptor Activation by 3,3 '-Diindolylmethane Suppresses Ovarian Tumor Growth In Vitro and In Vivo,” Journal Of Pharmacology And Experimental Therapeutics, vol. 341, no. 1, pp. 24–32, 2012. View at Publisher · View at Google Scholar
  • O. L. Polanovski, E. N. Lebedenko, and S. M. Deyev, “ERBB oncogene proteins as targets for monoclonal antibodies,” Biochemistry-Moscow, vol. 77, no. 3, pp. 227–245, 2012. View at Publisher · View at Google Scholar
  • Ying Dong, Yaowu He, Leonore de Boer, M. Sharon Stack, John W. Lumley, Judith A. Clements, and John D. Hooper, “The Cell Surface Glycoprotein CUB Domain-containing Protein 1 (CDCP1) Contributes to Epidermal Growth Factor Receptor-mediated Cell Migration,” Journal Of Biological Chemistry, vol. 287, no. 13, pp. 9792–9803, 2012. View at Publisher · View at Google Scholar
  • Jason A. Wilken, Tayf Badri, Sarah Cross, Rhoda Raji, Alessandro D. Santin, Peter Schwartz, Adam J. Branscum, Andre T. Baron, Adam I. Sakhitab, and Nita J. Maihle, “EGFR/HER-targeted therapeutics in ovarian cancer,” Future Medicinal Chemistry, vol. 4, no. 4, pp. 447–469, 2012. View at Publisher · View at Google Scholar
  • Sabrina L. Samudio-Ruiz, and Laurie G. Hudson, “Increased DNA methyltransferase activity and DNA methylation following epidermal growth factor stimulation in ovarian cancer cells,” Epigenetics, vol. 7, no. 3, pp. 216–224, 2012. View at Publisher · View at Google Scholar
  • Cheng Wang, Xiangmin Lv, Chao Jiang, Crystal M. Cordes, Lan Fu, Subodh M. Lele, and John S. Davis, “Transforming Growth Factor Alpha (TGF alpha) Regulates Granulosa Cell Tumor (GCT) Cell Proliferation and Migration through Activation of Multiple Pathways,” Plos One, vol. 7, no. 11, 2012. View at Publisher · View at Google Scholar
  • Jun He, Qing Xu, Yi Jing, Faton Agani, Xu Qian, Richard Carpenter, Qi Li, Xin-Ru Wang, Stephen S Peiper, Zhimin Lu, Ling-Zhi Liu, and Bing-Hua Jiang, “Reactive oxygen species regulate ERBB2 and ERBB3 expression via miR-199a/125b and DNA methylation,” EMBO reports, vol. 13, no. 12, pp. 1116–1122, 2012. View at Publisher · View at Google Scholar
  • Rexxi D. Prasasya, Kang Z. Vang, and Pamela K. Kreeger, “A multivariate model of ErbB network composition predicts ovarian cancer cell response to canertinib,” Biotechnology And Bioengineering, vol. 109, no. 1, pp. 213–224, 2012. View at Publisher · View at Google Scholar
  • Donavon Hiss, “Optimizing Molecular-Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways,” Journal of Oncology, vol. 2012, pp. 1–23, 2012. View at Publisher · View at Google Scholar
  • Hao-Wen Kao, Yi-Yu Lin, Chao-Cheng Chen, Kwan-Hwa Chi, Der-Chi Tien, Chien-Chung Hsia, Ming-Hsien Lin, and Hsin-Ell Wang, “Evaluation of EGFR-targeted radioimmuno-gold-nanoparticles as a theranostic agent in a tumor animal model,” Bioorganic & Medicinal Chemistry Letters, vol. 23, no. 11, pp. 3180–3185, 2013. View at Publisher · View at Google Scholar
  • Julia Frede, Scott P. Fraser, Gülten Oskay-Özcelik, Yeosun Hong, E. Ioana Braicu, Jalid Sehouli, Hani Gabra, and Mustafa B.A. Djamgoz, “Ovarian cancer: Ion channel and aquaporin expression as novel targets of clinical potential,” European Journal of Cancer, 2013. View at Publisher · View at Google Scholar
  • I. Rizvi, U. A. Gurkan, S. Tasoglu, N. Alagic, J. P. Celli, L. B. Mensah, Z. Mai, U. Demirci, and T. Hasan, “Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules,” Proceedings of the National Academy of Sciences, vol. 110, no. 22, pp. E1974–E1983, 2013. View at Publisher · View at Google Scholar
  • Elisabeth Smolle, Valentin Taucher, Martin Pichler, Edgar Petru, Sigurd Lax, and Johannes Haybaeck, “Targeting signaling pathways in epithelial ovarian cancer,” International Journal of Molecular Sciences, vol. 14, no. 5, pp. 9536–9555, 2013. View at Publisher · View at Google Scholar
  • Long Nguyen, Segundo Joel Cardenas-Goicoechea, Pierre Gordon, Christina Curtin, Mazdak Momeni, Linus Chuang, and David Fishman, “Biomarkers for early detection of ovarian cancer,” Women's Health, vol. 9, no. 2, pp. 171–187, 2013. View at Publisher · View at Google Scholar
  • Mark A. Marzinke, Caitlin H. Choi, Li Chen, Ie-Ming Shih, Daniel W. Chan, and Hui Zhang, “Proteomic Analysis of Temporally Stimulated Ovarian Cancer Cells for Biomarker Discovery,” Molecular & Cellular Proteomics, vol. 12, no. 2, pp. 356–368, 2013. View at Publisher · View at Google Scholar
  • J Kumar, F W Fraser, C Riley, N Ahmed, D R McCulloch, and A C Ward, “Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2/signal transducer and activator of transcription 3 in ovarian cancer,” British Journal of Cancer, 2013. View at Publisher · View at Google Scholar
  • Kristof Zarschler, Stefanie Witecy, Franz Kapplusch, Christian Foerster, and Holger Stephan, “High-yield production of functional soluble single-domain antibodies in the cytoplasm of Escherichia coli,” Microbial Cell Factories, vol. 12, 2013. View at Publisher · View at Google Scholar
  • Laurie Elit, and Hal Hirte, “Palliative systemic therapy for women with recurrent epithelial ovarian cancer: current options,” Oncotargets And Therapy, vol. 6, 2013. View at Publisher · View at Google Scholar
  • Stanley S. Stylli, Rodney B. Luwor, Andrew H. Kaye, T. T. Stacey, Christopher M. Hovens, and Peter Lock, “Expression of the adaptor protein Tks5 in human cancer: Prognostic potential,” Oncology Reports, vol. 32, no. 3, pp. 989–1002, 2014. View at Publisher · View at Google Scholar
  • Wuu-Jyh Lin, Fu-Du Chen, Ming-Hsien Lin, Hsin-Ell Wang, Hao-Wen Kao, Yi-Yu Lin, Chao-Cheng Chen, Kwan-Hwa Chi, Der-Chi Tien, and Chien-Chung Hsia, “Biological characterization of cetuximab-conjugated gold nanoparticles in a tumor animal model,” Nanotechnology, vol. 25, no. 29, pp. 295102, 2014. View at Publisher · View at Google Scholar
  • Shailendra Giri, Ramandeep Rattan, Mandar Deshpande, Jacie L. Maguire, Zachary Johnson, Rondell P. Graham, and Viji Shridhar, “Preclinical Therapeutic Potential of a Nitrosylating Agent in the Treatment of Ovarian Cancer,” Plos One, vol. 9, no. 6, 2014. View at Publisher · View at Google Scholar
  • Wai-Kin So, Jung-Chien Cheng, Qianlan Fan, Alice S.T. Wong, David G. Huntsman, C. Blake Gilks, and Peter C.K. Leung, “Loss of Sprouty2 in human high-grade serous ovarian carcinomas promotes EGF-induced E-cadherin down-regulation and cell invasion,” FEBS Letters, 2014. View at Publisher · View at Google Scholar
  • Michaela L. Granados, Laurie G. Hudson, and Sabrina L. Samudio-Ruiz, “Contributions of the Epidermal Growth Factor Receptor to Acquisition of Platinum Resistance in Ovarian Cancer Cells,” Plos One, vol. 10, no. 9, 2015. View at Publisher · View at Google Scholar
  • Yu Zhang, Guannan Guo, Ben Ma, Rong Du, Haihua Xiao, Xiaoguang Yang, Wenliang Li, Ying Gao, Yuxin Li, and Xiabin Jing, “A hybrid platinum drug dichloroacetate-platinum(II) overcomes cisplatin drug resistance through dual organelle targeting,” Anti-Cancer Drugs, vol. 26, no. 7, pp. 698–705, 2015. View at Publisher · View at Google Scholar
  • E. A. Kotelnikova, M. D. Logacheva, E. R. Nabieva, M. A. Pyatnitskiy, D. V. Vinogradov, A. S. Makarova, A. V. Demin, A. G. Paleeva, O. S. Kremenetskaya, A. A. Penin, A. V. Klepikova, A. S. Kasianov, D. A. Shavochkina, N. E. Kudashkin, Yu. I. Patyutko, N. S. Mugue, A. S. Kondrashov, and N. L Lazarevich, “NGS-based identification of druggable alterations and signaling pathways – hepatocellular carcinoma case report,” Biopolymers and Cell, vol. 31, no. 6, pp. 436–445, 2015. View at Publisher · View at Google Scholar
  • Hui-ju Yen, Yen-an Young, Tsung-neng Tsai, Kuang-ming Cheng, Xin-an Chen, Ying-chuan Chen, Cheng-cheung Chen, Jenn-jong Young, and Po-da Hong, “Positively charged gold nanoparticles capped with folate quaternary chitosan: Synthesis, cytotoxicity, and uptake by cancer cells,” Carbohydrate Polymers, 2017. View at Publisher · View at Google Scholar